|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, less allowances of $29 and $32, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Other Assets: | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, primarily trade names, service marks and trademarks, net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Long-term marketable securities | ||||||||||||||||||||
| Deferred customer acquisition costs | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Long-term assets of discontinued operations | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity: | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities: | ||||||||||||||||||||
| Payroll and related expenses | ||||||||||||||||||||
| Self-insured claims and related expenses | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Current portion of lease liability | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-Term Debt | ||||||||||||||||||||
| Other Long-Term Liabilities: | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Other long-term obligations, primarily self-insured claims | ||||||||||||||||||||
| Long-term lease liability | ||||||||||||||||||||
| Long-term liabilities of discontinued operations | ||||||||||||||||||||
| Total Other Long-Term Liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Common stock $0.01 par value (authorized 2,000,000,000 shares with 149,359,858 shares issued and 121,523,419 outstanding at June 30, 2022 and 149,095,168 shares issued and 121,258,729 outstanding shares outstanding at December 31, 2021) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Less common stock held in treasury, at cost (27,836,439 shares at June 30, 2022 and December 31, 2021) | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...